We're thrilled to announce partnership with Green Cross Health to make our tech readily available at NZ pharmacies. Our CEO Damian Camp sat down with RNZ this morning to discuss how our #COVID19 immunity test be made available to Kiwis. @radionz@gxhnz https://t.co/03dBWOHPNm
We need to talk about vaccination & immunity side by side. Immune responses to vaccination vary, so optimal timing for boosters will vary. Orbis has made immunity testing quick & easy to determine your Covid-19 immunity level & make informed health decisions. @Parmjeet_Parmar
New studies confirm waning immunity over six months after vaccination, imposing greater urgency around booster shots for the elderly and vulnerable. https://t.co/cboqQiULuC
Watch Sir Ian Taylor get our test for his COVID-19 immunity level before leaving for the US. It's a game-changer, he says, to confirm his vaccination is providing protection against the virus.
#COVID19#Immunity#Booster
Orbis had the pleasure of testing two journalists from RNZ for their COVID-19 immunity. GP Dr Talemaitoga explained the results and how the test will be able to inform the timing of booster shots
#COVID19#Booster
Imagine being able to nip into a pharmacy, have a two-minute test and just 15 minutes later know how protected you are against Covid-19.
That's what New Zealand-based biotech Orbis hopes to make available in the not too distant future.
https://t.co/oBg8aFSD6c
UniServices-backed @OrbisDx, a company that makes complex medical testing simple and accessible, partners with @AirNZMedia to test staff's Covid-19 immunity levels.
Learn more: https://t.co/fbI58t5Mmg
Orbis has partnered with Air New Zealand in a trial to test a group of their frontline staff for their COVID-19 immunity levels. We're pleased to take this step forward in commercialising our technology. Read more here:
https://t.co/wRGjEvcqr7 @FlyAirNZ#COVID19
We're thrilled our tech has been selected for Sir Ian Taylor's self-isolation pilot. Our quantitative immunity test will quickly measure his COVID-19 immunity levels. This will be a key tool to safely resume travel and provide a viable alternative to managed quarantine. #Covid_19
Orbis’ quantitative immunity test can quickly and reliably confirm immunisation from vaccination, without prejudice to vaccine type or country of vaccination. This will be a critical tool for enabling people to return home or travel abroad, no matter where they’ve come from.
The NZ Ministry of Health says it doesn't recognise vaccines a person has received overseas. This is a problem not only for NZ but many countries around the world.
Harmonising the vaccine verification process to one reliable source - the immune system - will be invaluable in the face of multiple paper-based and digital methods, the potential for vaccine fraud, and variable immune responses to vaccination.
Great to have our Founding Scientist Prof. David Williams catch up with Mike Hosking to discuss how our immunity test accurately assesses a person's response to their #CovidVaccine within 15 minutes, to be an additional layer of protection directly at the border. @hoskingonzb
This platform has been designed to be used in high-volume locations like airports to assess a fully vaccinated individuals’ immune response to #Covid_19, but can also be used to regularly test people in high-risk occupations to ensure vaccine-induced immunity isn’t wearing off.
“Antibody testing isn’t the only answer but it is something that's different and that adds another layer of protection and decision and might enable you to shorten that period in isolation." https://t.co/AU1NktFtgZ
We’re really thrilled with the progress our team have made in developing our automated immunity testing platform. Only requiring a tiny blood sample, the technology will be capable of testing up to 15 people at a time with results reported within 15 minutes.
2/2 Immunity testing developed specifically for use at points of need like airports and quarantine facilities will be a critical tool in a risk-based framework approach to support the gradual reopening of our borders.
1/2 Announcement from @jacindaardern gives insight into NZ's border strategy. Like most other countries, NZ faces the challenge of assessing an traveler's risk level at the border. Vaccination is key, but so is testing vaccine efficacy and verifying the vaccine certificate.
New Zealand Prime Minister Jacinda Ardern has said that that the country's borders will remain closed until at least the end of the year https://t.co/f9bpba6crf
When talking about border reopening, @jacindaardern mentions needing 'layers of protection' to give confidence that vaccinated travelers aren't at risk of causing #Covid_19 resurgence. Immunity testing is an important layer to give a viable alternative to mandatory quarantine